Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1)

Life Sciences

Volumn 90, Issue 11-12, 2012, Pages 440-445

  Zarogiannis, Sotirios G ^a,b   Noah, James W ^b,c   Jurkuvenaite, Asta ^a,b   Steele, Chad ^d   Matalon, Sadis ^a,b   Noah, Diana L ^b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

Acute lung injury; H1N1 2009; Influenza A; Oseltamivir; Pandemic; Ribavirin

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 10; OSELTAMIVIR; RIBAVIRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; INFLAMMATION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LUNG INJURY; LUNG LAVAGE; MORTALITY; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TH1 CELL; TH2 CELL; VIRUS LOAD; WEIGHT REDUCTION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; DNA PRIMERS; FEMALE; INFLUENZA A VIRUS, H1N1 SUBTYPE; KAPLAN-MEIER ESTIMATE; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; REAL-TIME POLYMERASE CHAIN REACTION; RIBAVIRIN;

MUS;

EID: 84858077103     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.12.014     Document Type: Article

References (27)

1. D.A. Boltz, J.R. Aldridge Jr. , R.G. Webster, and E.A. Govorkova Drugs in development for influenza Drugs 70 2010 1349 1362
2. Centers for Disease Control and Prevention Estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States 2010
3. Centers for Disease Control and Prevention Update: influenza activity - United States 2009-2010 season MMWR 59 2010 901 908
4. K.M. Chan-Tack, J.S. Murray, and D.B. Birnkrant Use of ribavirin to treat influenza N Engl J Med 361 2009 1713 1714
5. X.W. Cheng, J. Lu, C.L. Wu, L.N. Yi, X. Xie, and X.D. Shi Three fatal cases of pandemic 2009 influenza A virus infection in Shenzhen are associated with cytokine storm Respir Physiol Neurobiol 175 2011 185 187
6. S. Crotty, C. Cameron, and R. Andino Ribavirin's antiviral mechanism of action: lethal mutagenesis? J Mol Med 80 2002 86 95 (Pubitemid 34169816)
7. V.M. Deyde, X. Xu, R.A. Bright, M. Shaw, C.B. Smith, and Y. Zhang Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide J Infect Dis 196 2007 249 257 (Pubitemid 47047464)
8. S. Duan, D.A. Boltz, P. Seiler, J. Li, K. Bragstad, and L.P. Nielsen Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets PLoS Pathog 6 2010 e1001022
9. W. Heagy, C. Crumpacker, P.A. Lopez, and R.W. Finberg Inhibition of immune functions by antiviral drugs J Clin Invest 87 1991 1916 1924
10. R.D. Hubmayr, and J.C. Farmer Should we "rescue" patients with 2009 influenza A(H1N1) and lung injury from conventional mechanical ventilation? Chest 137 2010 745 747
11. Y. Itoh, K. Shinya, M. Kiso, T. Watanabe, Y. Sakoda, and M. Hatta In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses Nature 460 2009 1021 1025
12. P. Leyssen, J. Balzarini, E. De Clercq, and J. Neyts The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase J Virol 79 2005 1943 1947 (Pubitemid 40459141)
13. P. Leyssen, E. De Clercq, and J. Neyts The anti-yellow fever virus activity of ribavirin is independent of error-prone replication Mol Pharmacol 69 2006 1461 1467
14. S. Matalon, B.A. Holm, and R.H. Notter Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant J Appl Physiol 62 1987 756 761 (Pubitemid 17066640)
15. R.B. Moss, R.T. Davey, R.T. Steigbigel, and F. Fang Targeting pandemic influenza: a primer on influenza antivirals and drug resistance J Antimicrob Chemother 65 2010 1086 1093
16. Q. Ning, D. Brown, J. Parodo, M. Cattral, R. Gorczynski, and E. Cole Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response J Immunol 160 1998 3487 3493 (Pubitemid 28164743)
17. J.W. Noah, D.L. Noah, and S. Matalon Influenza exerts continued pressure in an era of modern medicine Am J Respir Cell Mol Biol 41 2009 3 7
18. T. Rowe, D. Banner, A. Farooqui, D.C. Ng, A.A. Kelvin, and S. Rubino In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009 J Gen Virol 91 2010 2898 2906
19. Sgarbanti, L. Nencioni, D. Amatore, P. Coluccio, A. Fraternale, and P. Sale Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy Antioxid Redox Signal 15 2011 593 606
20. E. van der Vries, F.F. Stelma, and C.A. Boucher Emergence of a multidrug resistant pandemic influenza A (H1N1) virus N Engl J Med 363 2010 1381 1382
21. K.B. Walsh, J.R. Teijaro, P.R. Wilker, A. Jatzek, D.M. Fremgen, and S.C. Das Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus Proc Natl Acad Sci U S A 108 2011 12018 12023
22. S. Wang, T.Q. Le, N. Kurihara, J. Chida, Y. Cisse, and M. Yano Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza J Infect Dis 202 2010 991 1001
23. L.B. Ware, and M.A. Matthay The acute respiratory distress syndrome N Engl J Med 342 2000 1334 1349 (Pubitemid 30408719)
24. World Health Organization Pandemic (H1N1) 2009 update 112 2010
25. World Health Organization WHO guidelines for pharmacological management of pandemic influenza A (H1N1) 2009 and other influenza viruses. Part I - recommendations 2010
26. A.K. Yadav, S.F. Doran, A.A. Samal, R. Sharma, K. Vedagiri, and E.M. Postlethwait Mitigation of chlorine gas lung injury in rats by postexposure administration of sodium nitrite Am J Physiol Lung Cell Mol Physiol 300 2011 362 369
27. S.G. Zarogiannis, A. Jurkuvenaite, S. Fernandez, S.F. Doran, A.K. Yadav, and G.L. Squadrito Ascorbate and deferoxamine administration post chlorine exposure decrease mortality and lung injury in mice Am J Respir Cell Mol Biol 45 2011 386 392